Alkermes begins Vivitrol pilot study in prisoners - Pharmaceutical Business Review
Alkermes begins Vivitrol pilot study in prisonersPharmaceutical Business ReviewAlkermes has initiated a pilot study of Vivitrol (naltrexone for extended-release injectable suspension) in prisoners with a pre-incarceration history of opioid dependence.
Alkermes Initiates Open-Label Pilot Study Of VIVITROL® To Evaluate Impact On ... - TheStreet.com (press release)
Alkermes Initiates Open-Label Pilot Study Of VIVITROL® To Evaluate Impact On .
Another FDA hurdle for Orexigen obesity drug candidate - The Pharma Letter
Another FDA hurdle for Orexigen obesity drug candidateThe Pharma Letter.
Research Suggests Brain Chemistry Link In Alcohol Addiction - WAPT Jackson
Research Suggests Brain Chemistry Link In Alcohol AddictionWAPT JacksonCurrently, the main drug available to help addicts stay off alcohol and drugs that is approved by the US Food and Drug Administration is naltrexone.
The Challenges Of Treating Addicts With Borderline Personality Disorder - PsychCentral.com (blog)
The Challenges Of Treating Addicts With Borderline Personality DisorderPsychCentral.